Sex differences in stroke case fatality: A meta-analysis

Acta Neurologica Scandinavica

Volumn 128, Issue 1, 2013, Pages 1-8

  Zhou, G ^a   Nie, S ^a   Dai, L ^a   Wang, X ^a   Fan, W ^a  

^a No 425 Hospital of PLA   (China)

Author keywords

Case fatality; Meta analysis; Sex characteristics; Stroke

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; FATALITY; HUMAN; MEDICAL LITERATURE; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEX DIFFERENCE;

FEMALE; HUMANS; MALE; SEX DISTRIBUTION; SEX FACTORS; STROKE;

EID: 84879182045     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12091     Document Type: Article

References (63)

1. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the who monica project. World health organization monitoring trends and determinants in cardiovascular disease. Stroke 1995;26:361-7.
2. Jakovljević D, Salomaa V, Sivenius J et al. Seasonal variation in the occurrence of stroke in a finnish adult population. The finmonica stroke register. Finnish monitoring trends and determinants in cardiovascular disease. Stroke 1996;27:1774-9.
3. Giralt D, Domingues-Montanari S, Mendioroz M et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand 2012;125:83-90.
4. Glader EL, Stegmayr B, Norrving B et al. Sex differences in management and outcome after stroke: a swedish national perspective. Stroke 2003;34:1970-5.
5. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17, 370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 2005;24:123-8.
6. Saposnik G, Cote R, Phillips S et al. Stroke outcome in those over 80: a multicenter cohort study across canada. Stroke 2008;39:2310-17.
7. Reeves MJ, Fonarow GC, Zhao X, Smith EE, Schwamm LH. Quality of care in women with ischemic stroke in the gwtg program. Stroke 2009;40:1127-33.
8. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009;40:1082-90.
9. McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H. Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990. The minnesota heart survey. JAMA 1992;268:753-9.
10. Pessah-Rasmussen H, Engstrom G, Jerntorp I, Janzon L. Increasing stroke incidence and decreasing case fatality, 1989-1998: a study from the stroke register in malmo, sweden. Stroke 2003;34:913-18.
11. Sheikh K, Bullock CM. Effect of measurement on sex difference in stroke mortality. Stroke 2007;38:1085-7.
12. Bejot Y, Rouaud O, Durier J et al. Decrease in the stroke case fatality rates in a french population-based twenty-year study. A comparison between men and women. Cerebrovasc Dis 2007;24:439-44.
13. Reeves MJ, Bushnell CD, Howard G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008;7:915-26.
14. Lewsey JD, Gillies M, Jhund PS et al. Sex differences in incidence, mortality, and survival in individuals with stroke in scotland, 1986 to 2005. Stroke 2009;40:1038-43.
15. Palnum KD, Andersen G, Ingeman A, Krog BR, Bartels P, Johnsen SP. Sex-related differences in quality of care and short-term mortality among patients with acute stroke in denmark: a nationwide follow-up study. Stroke 2009;40:1134-9.
16. Qureshi AI, Suri MF, Zhou J, Divani AA. African american women have poor long-term survival following ischemic stroke. Neurology 2006;67:1623-9.
17. Ayala C, Croft JB, Greenlund KJ et al. Sex differences in us mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002;33:1197-201.
18. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke 2000;31:1833-7.
19. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a who collaborative study. Bull World Health Organ 1980;58:113-30.
20. Furlan AD, Pennick V, Bombardier C, van Tulder M. 2009 updated method guidelines for systematic reviews in the cochrane back review group. Spine (Phila Pa 1976) 2009;34:1929-41.
21. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
22. Benatru I, Rouaud O, Durier J et al. Stable stroke incidence rates but improved case-fatality in dijon, france, from 1985 to 2004. Stroke 2006;37:1674-9.
23. Bushnell CD, Griffin J, Newby LK et al. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006;37:1427-31.
24. Das SK, Banerjee TK, Biswas A et al. A prospective community-based study of stroke in kolkata, india. Stroke 2007;38:906-10.
25. Feigin VL, Wiebers DO, Nikitin YP, O'Fallon WM, Whisnant JP. Stroke epidemiology in novosibirsk, russia: a population-based study. Mayo Clin Proc 1995;70:847-52.
26. Rastenyte D, Cepaitis Z, Sarti C, Bluzhas J, Tuomilehto J. Epidemiology of stroke in kaunas, lithuania. First results from the kaunas stroke register. Stroke 1995;26:240-4.
27. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in rochester, minnesota, through 1989. Stroke 1996;27:373-80.
28. Kiyohara Y, Kubo M, Kato I et al. Ten-year prognosis of stroke and risk factors for death in a japanese community: the hisayama study. Stroke 2003;34:2343-7.
29. The international stroke trial (ist): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International stroke trial collaborative group. Lancet 1997;349:1569-81.
30. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engl J Med. 1995;333:1581-7.
31. Newby LK. Long-term oral platelet glycoprotein iib/iiia receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (symphony) trial. Symphony steering committee. Am Heart J 1999;138:210-18.
32. Topol EJ, Easton JD, Amarenco P et al. Design of the blockade of the glycoprotein iib/iiia receptor to avoid vascular occlusion (bravo) trial. Am Heart J 2000;139:927-33.
33. Sarti C, Tuomilehto J, Sivenius J et al. Stroke mortality and case-fatality rates in three geographic areas of finland from 1983 to 1986. Stroke 1993;24:1140-7.
34. Sarti C, Tuomilehto J, Sivenius J et al. Declining trends in incidence, case-fatality and mortality of stroke in three geographic areas of finland during 1983-1989. Results from the finmonica stroke register. J Clin Epidemiol 1994;47:1259-69.
35. Suzuki K, Sarti C, Tuomilehto J et al. Stroke incidence and case fatality in finland and in akita, japan: a comparative study. Neuroepidemiology 1994;13:236-44.
36. Ryglewicz D, Polakowska M, Lechowicz W et al. Stroke mortality rates in poland did not decline between 1984 and 1992. Stroke 1997;28:752-7.
37. Peltonen M, Stegmayr B, Asplund K. Time trends in long-term survival after stroke: the northern sweden multinational monitoring of trends and determinants in cardiovascular disease (monica) study, 1985-1994. Stroke 1998;29:1358-65.
38. Stegmayr B, Vinogradova T, Malyutina S, Peltonen M, Nikitin Y, Asplund K. Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in russia and sweden. Stroke 2000;31:2-8.
39. Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke 2001;32:2131-6.
40. Sarti C, Stegmayr B, Tolonen H, Mahonen M, Tuomilehto J, Asplund K. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the who monica project. Stroke 2003;34:1833-40.
41. Zhang LF, Yang J, Hong Z et al. Proportion of different subtypes of stroke in china. Stroke 2003;34:2091-6.
42. Sivenius J, Tuomilehto J, Immonen-Räihä P et al. Continuous 15-year decrease in incidence and mortality of stroke in finland: the finstroke study. Stroke 2004;35:420-5.
43. The world health organization monica project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. Who monica project principal investigators. J Clin Epidemiol 1988;41:105-14.
44. Bothig S. Who monica project: objectives and design. Int J Epidemiol 1989;18:S29-37.
45. Asplund K, Bonita R, Kuulasmaa K et al. Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the who monica stroke study. World health organization monitoring trends and determinants in cardiovascular disease. Stroke 1995;26:355-60.
46. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998;17:841-56.
47. Di Carlo A, Lamassa M, Baldereschi M et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in europe: data from a multicenter multinational hospital-based registry. Stroke 2003;34:1114-19.
48. Kapral MK, Fang J, Hill MD et al. Sex differences in stroke care and outcomes: results from the registry of the canadian stroke network. Stroke 2005;36:809-14.
49. Wester P, Radberg J, Lundgren B, Peltonen M. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and tia: a prospective, multicenter study. Seek- medical-attention-in-time study group. Stroke 1999;30:40-8.
50. Foerch C, Misselwitz B, Humpich M, Steinmetz H, Neumann-Haefelin T, Sitzer M. Sex disparity in the access of elderly patients to acute stroke care. Stroke 2007;38:2123-6.
51. Smith MA, Lisabeth LD, Brown DL, Morgenstern LB. Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology 2005;65:855-8.
52. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in scottish primary care. Stroke 2005;36:1771-5.
53. Worrall BB, Johnston KC, Kongable G, Hung E, Richardson D, Gorelick PB. Stroke risk factor profiles in african american women: an interim report from the african-american antiplatelet stroke prevention study. Stroke 2002;33:913-19.
54. Niwa Y, Ishikawa S, Gotoh T, Kayaba K, Nakamura Y, Kajii E. Association between stroke and metabolic syndrome in a japanese population: Jichi medical school (jms) cohort study. J Epidemiol 2010;20:62-9.
55. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 2009;338:b664.
56. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000;284:72-8.
57. Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-74.
58. de Leciñana MA, Egido JA, Fernández C et al. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007;68:33-8.
59. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
60. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
61. Bonita R, Broad JB, Beaglehole R. Changes in stroke incidence and case-fatality in auckland, new zealand, 1981-91. Lancet 1993;342:1470-3.
62. Bonita R, Anderson CS, Broad JB, Jamrozik KD, Stewart-Wynne EG, Anderson NE. Stroke incidence and case fatality in australasia. A comparison of the auckland and perth population-based stroke registers. Stroke 1994;25:552-7.
63. Palm F, Urbanek C, Wolf J et al. Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke registry. Cerebrovasc Dis 2012;33:69-75.